Info
Schedule 13D/G History

BIOTECHNOLOGY VALUE FUND L P - Significant Ownership

Signature - Title: Biotechnology Value Fund L P - Mark N. Lampert, Authorized Signatory
Location: San Francisco, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOTECHNOLOGY VALUE FUND L P.

Significant Ownership of BIOTECHNOLOGY VALUE FUND L P

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
XOMA	XOMA Royalty Corp	Common Stock, $0.0075 par value	25.3%	$59.5M		2.98M		BVF GP HOLDINGS LLC	Jan 24, 2025
EPIX	ESSA Pharma Inc.	Common Shares	19.7%	$13.8M		8.75M		BVF PARTNERS L P/IL	Apr 9, 2025
VSTM	Verastem, Inc.	Common Stock, $0.0001 par value per share	9.99%	$28.4M		4.71M		BVF PARTNERS L P/IL	Dec 31, 2024
CDTX	Cidara Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.99%	$24.6M		1.09M		BVF PARTNERS L P/IL	Dec 31, 2024
FDMT	4D Molecular Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.99%	$15.6M		4.83M		BVF PARTNERS L P/IL	Dec 31, 2024
AVTX	Avalo Therapeutics, Inc.	Common Stock, $0.001 par value per share	9.99%	$8.31M		1.04M		BVF PARTNERS L P/IL	Dec 31, 2024
FBRX	Forte Biosciences, Inc.	Common Stock, $0.001 par value	9.99%	$5.28M		644K		BVF PARTNERS L P/IL	Dec 31, 2024
VTGN	Vistagen Therapeutics, Inc.	Common Stock, par value $0.001 per share	9.97%	$7.71M		3.08M		BVF PARTNERS L P/IL	Dec 31, 2024
IVA	Inventiva S.A.	Ordinary Shares, nominal value EUR0.01 per share	9%	$25.1M		8.55M		BVF PARTNERS L P/IL	Dec 19, 2024
RAPT	RAPT Therapeutics, Inc.	Common Stock, $0.0001 par value per share	8.7%	$14.4M		11.8M		BVF PARTNERS L P/IL	Dec 27, 2024
IKNA	Ikena Oncology, Inc.	Common Stock, par value $0.001 per share	8.3%	$3.45M		4.01M		BVF PARTNERS L P/IL	Dec 31, 2024
TYRA	Tyra Biosciences, Inc.	Common Stock, $0.0001 par value per share	7.8%	$36.7M		3.94M		BVF PARTNERS L P/IL	Dec 31, 2024
KURA	Kura Oncology, Inc.	Common Stock, par value $0.0001 per share	7.5%	$39M	$16.5M	5.91M	+73.5%	BVF PARTNERS L P/IL	Jan 27, 2025
GLUE	Monte Rosa Therapeutics, Inc.	Common Stock, $0.0001 par value per share	7.2%	$20.4M		4.39M		BVF PARTNERS L P/IL	Jan 24, 2025
ETNB	89bio, Inc.	Common Stock, par value $0.001 per share	3.6%	$31.5M		4.33M		BVF PARTNERS L P/IL	Dec 31, 2024
ENGN	enGene Holdings Inc.	Common Shares, no par value per share	1.8%	$4.41M	-$9.81M	945K	-69%	BVF PARTNERS L P/IL	Jan 27, 2025
THRD	Third Harmonic Bio, Inc.	Common Stock, par value $0.0001 per share	0%	$0		0		BIOTECHNOLOGY VALUE FUND L P	Apr 14, 2025

Showing 1 to 17 of 17 entries

Schedules 13D/G Reported by BIOTECHNOLOGY VALUE FUND L P:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.